Chungcheongbuk-do, South Korea

Dae-Seop Shin


Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Dae-Seop Shin: Innovator in Cancer Treatment

Introduction

Dae-Seop Shin is a prominent inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel pharmaceutical compounds. With a total of 2 patents, his work focuses on the prevention and treatment of cancer.

Latest Patents

One of Dae-Seop Shin's latest patents involves obovatol derivatives or pharmaceutically acceptable salts thereof, along with a preparation method and a pharmaceutical composition for cancer prevention and treatment. This patent discloses novel obovatol derivatives that have the ability to inhibit the growth of cancer cells and induce apoptosis. These derivatives are valuable in the fight against cancer and in suppressing cancer metastasis.

Another significant patent is an agent for the prevention and treatment of cancer that comprises an oxadiazole urea compound. This compound effectively inhibits the growth of cancer cell lines and the activity of STAT3, making it a promising candidate for cancer therapy.

Career Highlights

Dae-Seop Shin is affiliated with the Korea Research Institute of Bioscience and Biotechnology, where he conducts his research. His work is characterized by a strong focus on developing effective treatments for cancer, showcasing his commitment to advancing medical science.

Collaborations

Dae-Seop Shin collaborates with notable colleagues, including Byoung-Mog Kwon and Dong Cho Han. Their combined expertise contributes to the innovative research being conducted at the institute.

Conclusion

Dae-Seop Shin's contributions to cancer treatment through his patents and research highlight his role as a key innovator in the field. His work not only advances scientific knowledge but also holds the potential to improve patient outcomes in cancer therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…